Core Viewpoint - Spectral AI, Inc. is addressing potential market manipulation of its stock, particularly through naked short selling, which is believed to negatively impact its share price and that of other de-SPAC transaction companies [1][2]. Company Overview - Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics, specifically aimed at improving treatment decisions in wound care [9]. - The company’s DeepView System is designed to provide clinicians with an objective assessment of a wound's healing potential, thereby enhancing patient outcomes and reducing healthcare costs [9]. Recent Initiatives - Under the leadership of Erich Spangenberg, the company has reached out to Nasdaq and state securities authorities in Florida, Louisiana, and Texas to report potential violations related to naked short selling [7]. - The company has filed letters with the SEC regarding these concerns, with the latest letter dated July 15, 2024, to be made available via Form 8-K [8].
Spectral AI Continues Support of Naked Short Selling Inquiry